本页面由Tiger Trade Technology Pte. Ltd.提供服务

ANI Pharmaceuticals, Inc.

73.89
+1.912.65%
盘后:73.890.00000.00%19:30 EDT
成交量:54.08万
成交额:3,984.12万
市值:16.97亿
市盈率:16.27
高:74.43
开:71.87
低:71.25
收:71.98
52周最高:97.00
52周最低:69.58
股本:2,297.04万
流通股本:2,028.20万
量比:1.50
换手率:2.67%
股息:- -
股息率:- -
每股收益(TTM):4.54
每股收益(LYR):3.32
净资产收益率:20.46%
总资产收益率:5.45%
市净率:2.84
市盈率(LYR):22.26

数据加载中...

2024/03/07

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/03/06

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/03/05

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/02/29

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/02/29

重要事件披露

Form 8-K - Current report
2024/02/23

重要事件披露

Form 8-K - Current report
2024/02/14

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/02/12

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/02/08

重要事件披露

Form 8-K - Current report
2024/01/24

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/01/23

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/01/19

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/01/19

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/01/18

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/01/17

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2024/01/17

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/01/08

重要事件披露

Form 8-K - Current report
2023/12/20

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/12/18

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2023/12/18

关联方拟减持公告

Form 144 - Report of proposed sale of securities